Efficacy and Safety of Recombinant Factor VII as Rescue for Severe Perioperative Bleeding in HeartMate II Recipients

E-ISSN： 1540-8191|30|6|500-505

ISSN： 0886-0440

Source： JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol.30, Iss.6, 2015-06, pp. : 500-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 2, 2012-03 ,pp. : 139-150

Karger

Access to resources Recommend Favorite

Perioperative Use of Recombinant Factor VII to Prevent Intraoperative Aneurysm Rupture in High Risk Patients: A Preliminary Safety Evaluation

By Nussbaum Eric

Neurocritical Care, Vol. 10, Iss. 1, 2009-02 ,pp. : 55-60

Humana Press, Inc

Access to resources Recommend Favorite

Recombinant Activated Factor VII as a General Haemostatic Agent:Evidence-Based Efficacy and Safety

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 155-161

Bentham Science Publishers

Access to resources Recommend Favorite

Principles of HeartMate II Implantation to Avoid Pump Malposition and Migration

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 30, Iss. 3, 2015-03 ,pp. : 296-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation

By Gielen-Wijffels S. Mook W. Geest S. Ramsay G.

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1232-1234

Springer Publishing Company

Access to resources Recommend Favorite